Wuxi Biologics (Cayman), Inc. (2269)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 21, 2025

$2.34

P/E Ratio

26.63

Market Cap

$9.6B

Jan 25, 2024Feb 29, 2024Apr 3, 2024May 6, 2024Jun 10, 2024Jul 16, 2024Aug 19, 2024Sep 24, 2024Oct 29, 2024Dec 3, 2024Jan 21, 2025$0.00$10.00$20.00
  • IRBT
Description

Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.

Metrics

Overview

  • HQWuxi, JS
  • SectorHealth Technology
  • IndustryBiotechnology
  • Ticker2269
  • Price$2.338265-2.67%

Trading Information

  • Market cap$9.60B
  • Float85.18%
  • Average Daily Volume (1m)40,094,716
  • Average Daily Volume (3m)49,806,721
  • EPS$0.90

Company

  • Revenue$18.82B
  • Rev growth (1yr)6.01%
  • Net incomeN/A
  • Gross marginN/A
  • EBITDA margin31.22%
  • EBITDAN/A
  • EVN/A
  • EV/Revenue6.66
  • P/E26.63
  • P/S4.18
  • P/B1.73
Documents